Pairing polysomnography results with machine learning algorithms can predict individual-level results on sleep latency tests, a new study finds.
The prevalence of hypersomnia disorders — neurologic conditions characterized by bouts of sleepiness — is grossly underestimated. The shortage of effective therapies may be eased by several new clinical drug trials.
A new lower-sodium product is the latest in a wave of novel therapies with differing mechanisms of action that are improving quality of life for people with narcolepsy and its associated symptoms.
A long-term study has confirmed the durability of benefits and safety of a newly FDA-approved drug to treat excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea.